Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fbffdb96-6605-4c75-a92b-ecbfdce86d82/
UTHR
United Therapeutics CorporationSnapshot 2026-07-12 · 0.7w · Fresh
Strategy Eligibility
5 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 22%
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
9.8%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 85%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 2.16
V
Value Analysis
Cheapness relative to fundamentals
31.0%ile
P/E
18.0×
P/S
7.3×
P/B
3.9×
E/P
0.0734
FCF Yield
0.095
EBITDA/EV
0.077
SH Yield
0.098
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
80.00000000
/100 — 1=cheapest
VC2 (Trending Value)
70.00000000
/100
VC3 (Buyback)
71.00000000
/100
FCF yield of 9.5% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
96.0%ile
ROE
0.218
ROA
0.192
Net Margin
0.406
Op Margin
0.513
GPA
0.409
D/E
0.14
Current
4.79
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.059
Earn Growth
0.063
Stability
0.095
lower=better
Accruals
-0.041
lower=better
5yr Consist
Yes
ROE of 22% is exceptional. Conservative balance sheet with D/E of 0.14.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
93.0%ile
6M Return
13.2%
12M Return
85.1%
12-1 Mom
84.7%
Risk-Adj
2.16
Vol 252d
39.2%
Vol 60d
55.9%
↑ Expanding
Max DD 12M
-10.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 85% is very strong — a clear uptrend. Risk-adjusted momentum of 2.16 is excellent — strong returns relative to volatility. Near-term vol (56%) is expanding vs long-term (39%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.78
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
11.0%
Sector Quality %ile
95.8%
P/E z-score
-0.20
P/B z-score
-0.15
Sector Avg OS
63.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (96th) and momentum (93th) but expensive (31th value). Premium priced — watch for mean reversion.
Strong Capital Return
Shareholder yield 9.8% backed by 9.5% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (56%) significantly exceeds 252-day (39%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
63.9% avg (7 factors)
Quality
A
89.1% avg (8 factors)
Momentum
A
83.2% avg (4 factors)
Risk
C
51.3% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is confirming the value — this is the Trending Value signal that O'Shaughnessy found to be among the most powerful.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.780 | —6 | — | |
| Value %ile | 0.310 | —0 | — | |
| Quality %ile | 0.960 | —6 | — | |
| Momentum %ile | 0.930 | —6 | — | |
| F-Score | 7.000 | —6 | — | |
| Confidence | 0.920 | —6 | — | |
| Volatility | 0.392 | —0 | — |
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
18.04
Earnings Yield (E/P)
0.0734
Price / Sales
7.33
Price / Book
3.94
Price / Cash Flow
14.85
FCF Yield
9.5%
EBITDA / EV
7.7%
Sales Yield (1/P·S)
0.1431
Shareholder Yield
Div + net buyback / mktcap
9.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
21.8%
Return on Assets
19.2%
Net Margin
40.6%
Operating Margin
51.3%
Gross Profit / Assets
Novy-Marx GPA
40.9%
Debt / Equity
0.14
Current Ratio
4.79
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.041
External Financing
Net issuance — lower=better
0.410
MomentumPrice trend strength over different horizons
6M Return
13.2%
12M Return
85.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
84.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
2.16
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
5.9%
Earnings Growth (YoY)
6.3%
Earnings Stability (CV)
Lower = more stable
0.095
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Buyback Yield
9.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
80
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
70
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
71
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity